Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label adaptive multiple-dose study of radiprodil in drug-resistant infantile spasms
2016-002107-26Phase 2Terminated
- Sponsor
- UCB
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of radiprodil in West syndrome, sponsored by UCB. Primary endpoints: Safety and tolerability of multiple-dose radiprodil (Part A), Pharmacokinetics of radiprodil (Part A) and 1 more. Started Aug 2016; status: terminated.
02
Drugs
radiprodil
03
Conditions
West syndrome
Beyond the preview
Go deeper on 2016-002107-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002107-26.